Citi has lowered its 2025 economic growth forecast for Japan, citing escalating U.S. trade tariffs and weakening global demand. The investment bank now expects Japan’s GDP to grow just 0.9% in 2025, down from its previous 1.4% estimate. The 2026 GDP forecast was also trimmed to 0.8% from 1.1%.
The revised outlook reflects increased trade tensions under U.S. President Donald Trump’s renewed tariff strategy. Though a 24% tariff on Japanese goods was delayed by 90 days, a 10% blanket tariff and a 25% automobile tariff are moving forward. In addition, Trump’s 145% tariff on Chinese imports has triggered retaliation from Beijing, sparking a new phase in the U.S.-China trade war.
Japan, with its strong export ties to both countries, is facing growing risks. Citi noted that declining export demand, slower capital spending, and global economic uncertainty—especially in China—are set to weigh on Japan’s growth prospects. Despite these challenges, a recession in Japan is not expected. Citi forecasts resilient personal consumption, supported by anticipated robust spring wage increases.
Citi also revised its interest rate expectations, predicting that the Bank of Japan will now delay its next rate hike until March 2026, a shift from earlier projections of a June 2025 increase. The BOJ’s terminal rate is still projected to peak at 1.5%.
Inflation in Japan remains a key concern, with Citi expecting core consumer prices to rise 2.5% in 2025.
The evolving trade landscape poses significant challenges to Japan’s export-driven economy, with potential supply chain disruptions adding further pressure. As geopolitical tensions rise, Japan’s ability to navigate shifting global trade policies will be critical to sustaining economic stability.


Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Trump's Claim That the U.S. Can Cover Global Jet Fuel Shortfall Doesn't Add Up
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Asian Stocks Drop as Trump Signals Iran War Escalation
Trump Threatens Escalation Against Iran, Warns of Infrastructure Strikes
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Asian Stocks Surge on Trump's Iran War Comments and Dip-Buying
RBI Clamps Down on Rupee NDF Activity, Banks Face Steeper Losses
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
South Korea's Inflation Rises Modestly in March Amid Oil Price Pressures
Trump's Iran War Speech Sparks Market Anxiety Over Extended Conflict
Oil Prices Climb as Middle East Conflict Keeps Supply Risks Elevated
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
Japan's Business Confidence Rises Despite Iran War Uncertainty, BOJ Rate Hike Expected 



